Behçet Ayten, Taslimi Parham, Şen Betül, Taskın-Tok Tuğba, Aktaş Aydın, Gök Yetkin, Aygün Muhittin, Gülçin İlhami
Department of Chemistry, Faculty of Science and Arts, Inonu University, Malatya, Türkiye.
Department of Biotechnology, Faculty of Science, Bartin University, Bartin, Türkiye.
J Biochem Mol Toxicol. 2024 Jan;38(1):e23554. doi: 10.1002/jbt.23554. Epub 2023 Oct 19.
This work includes the synthesis of a new series of palladium-based complexes containing both morpholine and N-heterocyclic carbene (NHC) ligands. The new complexes were characterized using NMR ( H and C), FTIR spectroscopic, and elemental analysis techniques. The crystal structure of complex 1b was obtained by utilizing the single-crystal X-ray diffraction method. X-ray studies show that the coordination environment of palladium atom is completed by the carbene carbon atom of the NHC ligand, the nitrogen atom of the morpholine ring, and a pair of bromide ligand, resulting in the formation of slightly distorted square planar geometry. All complexes were determined for some metabolic enzyme activities. Results indicated that all the synthetic complexes exhibited powerful inhibitory actions against all aims as compared to the control molecules. K values of new morpholine-liganded complexes bearing 4-hydroxyphenylethyl group 1a-e for hCA I, hCA II, AChE, BChE, and α-glycosidase enzymes were obtained in the ranges 0.93-2.14, 1.01-2.03, 4.58-10.27, 7.02-13.75, and 73.86-102.65 µM, respectively. Designing of reported complexes is impacted by molecular docking study, and interaction with the current enzymes also proclaimed that compounds 1e (-12.25 kcal/mol for AChE and -11.63 kcal/mol for BChE), 1c (-10.77 kcal/mol and -9.26 kcal/mol for α-Gly and hCA II, respectively), and 1a (-8.31 kcal/mol for hCA I) are showing binding affinity and interaction from the synthesized five novel complexes.
这项工作包括合成一系列新的含有吗啉和N-杂环卡宾(NHC)配体的钯基配合物。使用核磁共振(氢谱和碳谱)、傅里叶变换红外光谱和元素分析技术对新配合物进行了表征。配合物1b的晶体结构通过单晶X射线衍射法获得。X射线研究表明,钯原子的配位环境由NHC配体的卡宾碳原子、吗啉环的氮原子和一对溴配体完成,形成了略有扭曲的平面正方形几何结构。测定了所有配合物的一些代谢酶活性。结果表明,与对照分子相比,所有合成配合物对所有目标均表现出强大的抑制作用。带有4-羟基苯乙基的新型吗啉配体配合物1a-e对人碳酸酐酶I(hCA I)、人碳酸酐酶II(hCA II)、乙酰胆碱酯酶(AChE)、丁酰胆碱酯酶(BChE)和α-糖苷酶的K值分别在0.93 - 2.14、1.01 - 2.03、4.58 - 10.27、7.02 - 13.75和73.86 - 102.65 μM范围内。所报道配合物的设计受到分子对接研究的影响,并且与当前酶的相互作用也表明,化合物1e(对AChE为-12.25 kcal/mol,对BChE为-11.63 kcal/mol)、1c(对α-糖苷酶和hCA II分别为-10.77 kcal/mol和-9.26 kcal/mol)以及1a(对hCA I为-8.31 kcal/mol)在合成的五种新型配合物中表现出结合亲和力和相互作用。